Jens Nielsen’s Post

View profile for Jens Nielsen, graphic

CEO at BioInnovation Institute

At BioInnovation Institute, we support early-stage innovation to create a long-lasting impact.   Scientific-based innovation often takes a long time before it reaches the market and society, but to succeed, it requires investors who are in it for the long haul and do not expect a fast return on investment.   But taking this into account, how does an investor assess the value of early-stage scientific-based innovation? I will ask this question to the talented Karen Firestone, who will join us for a ‘Talks at the Square’ on 28 October. You can sign up here: https://bit.ly/3YdLSri

  • No alternative text description for this image
Line Holst Graves

Commercial Growth Strategist and Advisor | Guiding Biotech & Planetary Health Founders Through Commercial Expansion To Secure High-Value Customers & Strategic Partnerships

1mo

Great to see BioInnovation Institute’s commitment to fostering early-stage innovation! It’s crucial to have patient investors who understand the timeline required for scientific breakthroughs. Looking forward to the insights Karen Firestone will share on how investors assess the value of these innovations. Exciting conversation ahead!

Interesting

Like
Reply

Highly recommended! #NordicMade #NordicStartups #DeepTech #BII

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics